SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein

被引:16
|
作者
Walter, Marius [1 ,6 ]
Chen, Irene P. [2 ,3 ,4 ]
Vallejo-Gracia, Albert [2 ,3 ,4 ]
Kim, Ik-Jung [1 ]
Bielska, Olga [1 ]
Lam, Victor L. [3 ]
Hayashi, Jennifer M. [2 ,3 ,4 ]
Cruz, Andrew [1 ]
Shah, Samah [1 ]
Soveg, Frank W. [2 ,3 ,4 ]
Gross, John D. [3 ,5 ]
Krogan, Nevan J. [2 ,3 ,4 ,5 ]
Jerome, Keith R. [6 ,7 ]
Schilling, Birgit [1 ]
Ott, Melanie [2 ,3 ,4 ,8 ]
Verdin, Eric [1 ]
机构
[1] Buck Inst Res Aging, Novato, CA 94945 USA
[2] Gladstone Inst, San Francisco, CA USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] QBI COVID 19 Res Grp QCRG, San Francisco, CA USA
[5] Univ Calif San Francisco, Quantitat Biosci Inst QBI, San Francisco, CA 94143 USA
[6] Fred Hutch Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA
[7] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[8] Chan Zuckerberg Biohub, San Francisco, CA USA
关键词
FUNCTIONAL-ANALYSIS; RNA VIRUS; CORONAVIRUS; EXORIBONUCLEASE; DESUCCINYLATION; METABOLISM; PROMOTES; EXCISION;
D O I
10.1371/journal.ppat.1010811
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
SARS-CoV-2 non structural protein Nsp14 is a highly conserved enzyme necessary for viral replication. Nsp14 forms a stable complex with non-structural protein Nsp10 and exhibits exoribonuclease and N7-methyltransferase activities. Protein-interactome studies identified human sirtuin 5 (SIRT5) as a putative binding partner of Nsp14. SIRT5 is an NAD-dependent protein deacylase critical for cellular metabolism that removes succinyl and malonyl groups from lysine residues. Here we investigated the nature of this interaction and the role of SIRT5 during SARS-CoV-2 infection. We showed that SIRT5 interacts with Nsp14, but not with Nspl 0, suggesting that SIRT5 and Nsp10 are parts of separate complexes. We found that SIRT5 catalytic domain is necessary for the interaction with Nsp14, but that Nsp14 does not appear to be directly deacylated by SIRT5. Furthermore, knock-out of SIRT5 or treatment with specific SIRT5 inhibitors reduced SARS-CoV-2 viral levels in cellculture experiments. SIRT5 knock-out cells expressed higher basal levels of innate immunity markers and mounted a stronger antiviral response, independently of the Mitochondrial Antiviral Signaling Protein MAVS. Our results indicate that SIRT5 is a proviral factor necessary for efficient viral replication, which opens novel avenues for therapeutic interventions.
引用
收藏
页数:30
相关论文
共 50 条
  • [1] New insights into complex formation by SARS-CoV-2 nsp10 and nsp14
    Sele, Celeste
    Krupinska, Ewa
    Andersson Rasmussen, Anna
    Ekstrom, Simon
    Hultgren, Lucas
    Lou, Jiaqi
    Kozielski, Frank
    Fisher, S. Zoe
    Knecht, Wolfgang
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2024, 43 (08): : 798 - 812
  • [2] Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein
    Hsu, Jack Chun-Chieh
    Laurent-Rolle, Maudry
    Pawlak, Joanna B.
    Wilen, Craig B.
    Cresswell, Peter
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (24)
  • [3] SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants
    Hassan, Sk. Sarif
    Bhattacharya, Tanishta
    Nawn, Debaleena
    Jha, Ishana
    Basu, Pallab
    Redwan, Elrashdy M.
    Lundstrom, Kenneth
    Barh, Debmalya
    Andrade, Bruno Silva
    Tambuwala, Murtaza M.
    Aljabali, Alaa A.
    Hromic-Jahjefendic, Altijana
    Baetas-da-Cruz, Wagner
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    COMPUTERS IN BIOLOGY AND MEDICINE, 2024, 170
  • [4] Activation of the SARS-CoV-2 NSP14 3′-5′ exoribonuclease by NSP10 and response to antiviral inhibitors
    Riccio, Amanda A.
    Sullivan, Eric D.
    Copeland, William C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (01)
  • [5] Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene
    Tadaka, Kosuke
    Ueda, Mahoko Takahashi
    Shichinohe, Shintaro
    Kida, Yurie
    Ono, Chikako
    Matsura, Yoshiharu
    Watarbe, Tokiko
    Nakagawa, So
    ISCIENCE, 2023, 26 (03)
  • [6] On the Weak Binding and Spectroscopic Signature of SARS-CoV-2 nsp14 Interaction with RNA
    Hassan, Ayaz
    Sedenho, Graziela C.
    Vitale, Phelipe A. M.
    Oliviera, Mona N.
    Crespilho, Frank N.
    CHEMBIOCHEM, 2021, 22 (24) : 3410 - 3413
  • [7] Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2
    Liu, Chao
    Zhu, Xiaoxiao
    Lu, Yiyao
    Zhang, Xianqin
    Jia, Xu
    Yang, Tai
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2021, 11 (03) : 272 - 277
  • [8] Crystallographic structure of whole nsp14 from SARS-CoV-2 stabilised by a nanobody
    Gauffre, Pierre
    Gaubert, Anais
    Canard, Bruno
    Ferron, Francois
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2024, 80
  • [9] Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors
    Stefek, Milan
    Chalupska, Dominika
    Chalupsky, Karel
    Zgarbova, Michala
    Dvorakova, Alexandra
    Krafcikova, Petra
    Li, Alice Shi Ming
    Sala, Michal
    Dejmek, Milan
    Otava, Tomas
    Chaloupecka, Ema
    Kozak, Jaroslav
    Kozic, Jan
    Vedadi, Masoud
    Weber, Jan
    Mertlikova-Kaiserova, Helena
    Nencka, Radim
    ACS OMEGA, 2023, 8 (30): : 27410 - 27418
  • [10] Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2
    Chao Liu
    Xiaoxiao Zhu
    Yiyao Lu
    Xianqin Zhang
    Xu Jia
    Tai Yang
    Journal of Pharmaceutical Analysis, 2021, 11 (03) : 272 - 277